MAYNF Stock News Mayne Pharma (MAYNF) 0.8200 07/13/2014 21:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mayne Pharma (MAYNF) 0.8200 $MAYNF

HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials and Finalizes Key Agreement with Mayne Pharma
PR Newswire - Wed Jun 25, 8:15AM CDT
HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has closed a $1.5 million interim private common stock financing. The funds were secured from Hedgepath, LLC, HPPI's current majority stockholder. Under the terms of the financing, Hedgepath, LLC will purchase 20 million shares of HPPI common stock for gross proceeds of $1.5 million, which proceeds will be funded in pre-agreed to monthly tranches during the remainder of 2014.

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2014
M2 - Thu Jun 12, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zp6w5m/onychomycosis) has announced the addition of the "Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Onychomycosis (Tinea Unguium) and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Onychomycosis (Tinea Unguium) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Onychomycosis (Tinea Unguium) and enlists all their major and minor projects Companies Mentioned: - Actavis plc - Eisai Co., Ltd. - Nihon Nohyaku Co., Ltd. - Helix BioMedix, Inc. - Kaken Pharmaceutical Co., Ltd. - Apricus Biosciences, Inc. - NovaBay Pharmaceuticals, Inc. - Nuvo Research Inc. - Mayne Pharma Group Limited - Evolva SA - Novabiotics Ltd - Anacor Pharmaceuticals, Inc. - NB Therapeutics, Inc. - NanoBio Corporation - Moberg Pharma AB - Viamet Pharmaceuticals, Inc. - Celtic Pharmaceutical Holdings L.P. - Meiji Seika Pharma Co., Ltd. For more information visit http://www.researchandmarkets.com/research/zp...chomycosis

HedgePath Pharmaceuticals Enters into Key Collaboration with Mayne Pharma
PR Newswire - Tue Sep 10, 3:01PM CDT
HedgePath Pharmaceuticals, Inc. (OTCPink: HPPI) (HPPI) announced today that it has signed an exclusive Supply and License Agreement with Mayne Pharma International Pty Ltd (Mayne Pharma), a wholly owned subsidiary of Mayne Pharma Group Limited, an Australian ASX listed company, whereby HPPI will pursue clinical development of Mayne Pharma's patented formulation of the drug itraconazole, known as SUBA-Itraconazole, for treatment of a variety of cancers with a focus on seeking regulatory approvals and marketing in the United States.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 3

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Updated Category News Views 7

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Continue Reading
NYC's Carriage Horse Ban: A New Era for Urban Welfare

Updated Category News Views 4

You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...

Continue Reading
Basic Invite's Holiday Card Service Offers Saving Time

Updated Category News Views 1

Getting the Cards Out: Maneuvering the Holiday Hustle Alright, let's dive into the madness that is holiday card season. Could be a logistical nightmare or a nostalgic tradition, depending on your cup of tea. Basic Invite here is trying to cut through the chaos by bumping deadlines and offering some straight-out-the-gate mailing options. If you play your cards right—pun...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Celebrating Alexander Trost: A Lifetime of Compassionate Care

Updated Category News Views 4

A Legendary Career in Palliative Medicine You know, in a world where people glamorize stock flips and flashy earnings, it's refreshing to spotlight good old-fashioned compassion. Enter Dr. Alexander Trost, DNP, FNP-C, ACHPN. This fella has just been honored as a Pinnacle Lifetime Member by The Inner Circle—a nod to his impactful work in palliative medicine. You ever try...

Continue Reading
Tigo Energy Faces Class Action Over Revenue Claims

Updated Category News Views 3

Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...

Continue Reading
Rising Food Safety Stars Honored: A Global Effort

Updated Category News Views 2

Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 5

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaisala Corporation Executes Strategic Share Issuance for Growth

Updated Category News Views 125

Vaisala Corporation Executes Strategic Share Issuance Vaisala Corporation recently communicated an important milestone as part of its strategic operations. The company conveyed a total of 750 treasury shares without consideration to a participant in its Restricted Share Unit Plan 2022–2026, aligning with the terms of this initiative. This action reflects Vaisala's...

Continue Reading
Applied Materials Reports Strong Q3 but Offers Cautious Guidance

Updated Category News Views 165

Applied Materials Exceeds Earnings Expectations Applied Materials Inc (NASDAQ: AMAT) has announced its financial results for the third quarter, impressing analysts with a revenue of $7.3 billion, exceeding the anticipated $7.22 billion. This strong performance was highlighted in the earnings report released after the market closed on Thursday. Key Financial Performance...

Continue Reading
Limitless X Holdings, Inc. Secures SEC Qualification for Reg A+

Updated Category News Views 121

Limitless X Holdings, Inc. Achieves SEC Qualification for Offering Limitless X Holdings, Inc. (OTCQB: LIMX) operates with a mission to inspire individuals and enhance value for shareholders. Recently, the SEC qualified its Regulation A+ offering, marking a significant step forward for the company. Strategic Investment Opportunity This offering, characterized as Series D...

Continue Reading
Encamp Introduces Waste Command for Advanced RCRA Compliance

Updated Category News Views 166

Encamp Enhances Compliance with New Waste Command Encamp has recently launched an innovative tool called Waste Command, aiming to simplify hazardous waste management and compliance for enterprises. As a leading solution in environmental compliance, Encamp is known for its commitment to helping organizations navigate complex regulations effectively. Importance of...

Continue Reading
Reimagining Laundry: How all® free clear Enhances Skincare

Updated Category News Views 410

all® free clear Laundry Detergent: A Skincare Revolution Imagine walking into your laundry room and knowing that your detergent can do more than just clean clothes; it can also care for your skin. That’s exactly what all® free clear laundry detergent promotes as it launches a unique content series aimed at raising awareness around the link between laundry care and...

Continue Reading